View Cart (0 items)

Pharmaceutical

Monsanto Company Announces $300 Million Debt Issue

According to PRNewswire, Monsanto Company announced a 5-year, $300 million public debt offering. Notes will be issued at 99.787 percent and bear interest at 2.75 percent, resulting in a yield
Read More

Merck Fails to Win FDA Approval on Gardasil Use in Older Women

Bloomberg reports that Merck & Co. has failed to win U.S. approval to expand use of the cervical-cancer vaccine Gardasil to older women. The FDA didn’t grant the company’s application
Read More

Shire Files Lawsuit Against Watson Pharmaceuticals for Infringement

According to PRNewswire, Shire LLC has filed a lawsuit in the U.S. District Court for the Southern District of New York against Watson Pharmaceuticals, Inc. and its subsidiaries Watson Laboratories,
Read More

Abbott Ordered to Pay Glaxo $3.5 Million in Suit

Abbott Laboratories must pay GlaxoSmithKline $3.5 million in damages for breaching an agreement over an AIDS drug, reports Bloomberg. The jury cleared the company of claims that it sought
Read More

Mylan Introduces Educational Website About Generic Drugs

To help consumers better understand the true value, reliability and high quality of generics, Mylan Inc. has launched an educational website about generics drugs, www.ChoosingGenerics.com, reports PRNewswire. ChoosingGenerics.com calls on
Read More

Pfizer’s Steere to Retire

Bloomberg reports that Pfizer Inc.’s former chairman and CEO William Steere is retiring from the board after building the world’s biggest drugmaker with acquisitions and products led by the Lipitor
Read More

Bristol-Myers Shares Rise on Melanoma Drug Study

The Associated Press reports that shares of Bristol-Myers Squibb Co. rose Tuesday morning following an announcement that the company''s highly anticipated melanoma drug improved survival times when used as a
Read More

Law Firm Investigating Acquisition of The Lubrizol Corporation

According to Business Wire, Bull & Lifshitz, LLP recently announced an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of The Lubrizol Corporation by
Read More

Novartis Gets EU Approval for Oral MS Drug

Swiss drug maker Novartis AG says it has received European Union approval to sell its oral multiple sclerosis medication Gilenya in the 27-nation bloc, according to the Associated Press. The
Read More

J&J Cut CEO''s Pay Nine Percent Amid 2010 Recalls

According to the Associated Press, health care giant Johnson & Johnson lowered Chief Executive William Weldon''s total compensation by 9 percent in 2010, after two years of revenue declines and
Read More